Breast cancer is a complex and heterogeneous disease [41] which consists of four major clinically-relevant subtypes: luminal A, luminal B, triple-negative, and HER2+, which vary in prognosis and require distinct treatments [5,42]. This evidence concerns the gene ERBB2 and breast cancer.